75 related articles for article (PubMed ID: 8257919)
1. Adrenal response to adrenocorticotropin hormone and HLA typing of subjects with different degrees of 21-hydroxylase deficiency.
Elias LL; Voltarelli JC; Moreira AC
Braz J Med Biol Res; 1993 Feb; 26(2):177-89. PubMed ID: 8257919
[TBL] [Abstract][Full Text] [Related]
2. Genotype and hormonal phenotype in nonclassical 21-hydroxylase deficiency.
Speiser PW; New MI
J Clin Endocrinol Metab; 1987 Jan; 64(1):86-91. PubMed ID: 3023431
[TBL] [Abstract][Full Text] [Related]
3. Comparison of basal and adrenocorticotropin-stimulated plasma 21-deoxycortisol and 17-hydroxyprogesterone values as biological markers of late-onset adrenal hyperplasia.
Fiet J; Gueux B; Gourmelen M; Kuttenn F; Vexiau P; Couillin P; Pham-Huu-Trung MT; Villette JM; Raux-Demay MC; Galons H
J Clin Endocrinol Metab; 1988 Apr; 66(4):659-67. PubMed ID: 2831244
[TBL] [Abstract][Full Text] [Related]
4. Pituitary-adrenal responses to corticotropin-releasing hormone in different degrees of adrenal 21-hydroxylase deficiency.
Moreira AC; Elias LL
J Clin Endocrinol Metab; 1992 Jan; 74(1):198-203. PubMed ID: 1309366
[TBL] [Abstract][Full Text] [Related]
5. Attenuated forms of congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Lee PA; Rosenwaks Z; Urban MD; Migeon CJ; Bias WD
J Clin Endocrinol Metab; 1982 Nov; 55(5):866-71. PubMed ID: 6288754
[TBL] [Abstract][Full Text] [Related]
6. Effects of continued adrenocorticotropin stimulation on the mineralocorticoid hormones in classical and nonclassical simple virilizing types of 21-hydroxylase deficiency.
Kater CE; Biglieri EG; Wajchenberg B
J Clin Endocrinol Metab; 1985 Jun; 60(6):1057-62. PubMed ID: 2987285
[TBL] [Abstract][Full Text] [Related]
7. Isolated precocious pubarche: an approach.
Balducci R; Boscherini B; Mangiantini A; Morellini M; Toscano V
J Clin Endocrinol Metab; 1994 Aug; 79(2):582-9. PubMed ID: 8045980
[TBL] [Abstract][Full Text] [Related]
8. Hormonal phenotype and HLA-genotype in families of patients with congenital adrenal hyperplasia (21-hydroxylase deficiency).
Lorenzen F; Pang S; New MI; Dupont B; Pollack M; Chow DM; Levine LS
Pediatr Res; 1979 Dec; 13(12):1356-60. PubMed ID: 230448
[TBL] [Abstract][Full Text] [Related]
9. Absence of nonclassical congenital adrenal hyperplasia in patients with precocious adrenarche.
Morris AH; Reiter EO; Geffner ME; Lippe BM; Itami RM; Mayes DM
J Clin Endocrinol Metab; 1989 Oct; 69(4):709-15. PubMed ID: 2550505
[TBL] [Abstract][Full Text] [Related]
10. Cortisol response to adrenocorticotropin testing in non-classical congenital adrenal hyperplasia (NCCAH).
Karachaliou FH; Kafetzi M; Dracopoulou M; Vlachopapadopoulou E; Leka S; Fotinou A; Michalacos S
J Pediatr Endocrinol Metab; 2016 Dec; 29(12):1365-1371. PubMed ID: 27849625
[TBL] [Abstract][Full Text] [Related]
11. Serum cortisol and 17-hydroxyprogesterone interrelation in classic 21-hydroxylase deficiency: is current replacement therapy satisfactory?
Charmandari E; Matthews DR; Johnston A; Brook CG; Hindmarsh PC
J Clin Endocrinol Metab; 2001 Oct; 86(10):4679-85. PubMed ID: 11600525
[TBL] [Abstract][Full Text] [Related]
12. The hypothalamic-pituitary-adrenal axis in partial (late-onset) 21-hydroxylase deficiency.
Feuillan P; Pang S; Schürmeyer T; Avgerinos PC; Chrousos GP
J Clin Endocrinol Metab; 1988 Jul; 67(1):154-60. PubMed ID: 2837498
[TBL] [Abstract][Full Text] [Related]
13. Adrenocorticotropin stimulation test in congenital adrenal hyperplasia: comparison between standard and low dose test.
Panamonta O; Thinkhamrop B; Kirdpon W; Pudtawaro LO; Sungsahachart D
J Med Assoc Thai; 2003 Jul; 86(7):634-40. PubMed ID: 12948258
[TBL] [Abstract][Full Text] [Related]
14. 'Cryptic' form of congenital adrenal hyperplasia due to 21-hydroxylase deficiency in the Yugoslav population.
Dumić M; Brkljacić L; Mardesić D; Plavsić V; Lukenda M; Kastelan A
Acta Endocrinol (Copenh); 1985 Jul; 109(3):386-92. PubMed ID: 2992207
[TBL] [Abstract][Full Text] [Related]
15. Incidental adrenal nodules: association with exaggerated 17-hydroxyprogesterone response to adrenocorticotropic hormone.
Turton DB; O'Brian JT; Shakir KM
J Endocrinol Invest; 1992 Dec; 15(11):789-96. PubMed ID: 1337905
[TBL] [Abstract][Full Text] [Related]
16. A contribution to the classification of cases of non-classic 21-hydroxylase-deficient congenital adrenal hyperplasia.
Phocas I; Chryssikopoulos A; Sarandakou A; Rizos D; Trakakis E
Gynecol Endocrinol; 1995 Sep; 9(3):229-38. PubMed ID: 8540293
[TBL] [Abstract][Full Text] [Related]
17. Pitfalls of prenatal diagnosis of 21-hydroxylase deficiency congenital adrenal hyperplasia.
Pang S; Pollack MS; Loo M; Green O; Nussbaum R; Clayton G; Dupont B; New MI
J Clin Endocrinol Metab; 1985 Jul; 61(1):89-97. PubMed ID: 3873469
[TBL] [Abstract][Full Text] [Related]
18. New reliable biochemical marker for screening 21 alpha-hydroxylase deficiency without index person among hirsute women in agreement with HLA-haplotyping.
Chryssikopoulos A; Phocas I; Sarandakou A; Trakakis E; Rizos D
J Endocrinol Invest; 1995 Nov; 18(10):754-61. PubMed ID: 8787951
[TBL] [Abstract][Full Text] [Related]
19. Adrenocorticotrophin stimulation and HLA polymorphisms suggest a high frequency of heterozygosity for steroid 21-hydroxylase deficiency in patients with Turner's syndrome and their families.
Larizza D; Cuccia M; Martinetti M; Maghnie M; Dondi E; Salvaneschi L; Severi F
Clin Endocrinol (Oxf); 1994 Jan; 40(1):39-45. PubMed ID: 8306479
[TBL] [Abstract][Full Text] [Related]
20. HLA typing and ACTH stimulation in the detection of carriers for 21-hydroxylase deficiency.
Stuckey MS; Boyne P; Macdonald WB; Christiansen FT; Houliston JB; Dawkins RL
Aust N Z J Med; 1980 Oct; 10(5):552-4. PubMed ID: 6258552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
